NOCRI Innovative Medicines Initiative

Innovative Medicines Initiative

Follow NOCRI on twitter: @NIHR_NOCRI<https://twitter.com/NIHR_NOCRI>

[http://gallery.mailchimp.com/90445357df0daade3979189e5/images/nihr_logo_BIO_cmyk.jpg] <http://www.nocri.nihr.ac.uk> Innovative Medicines Initiative (second phase) to launch in July 2014

The second phase of the Innovative Medicines Initiative <http://www.imi.europa.eu/content/home> (IMI2) has published indicative texts for the two topics of its first call, which are due to be launched in July 2014.

CALL TOPICS

CALL 1 – July 2014

Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM) Indicative Text<http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_Call1/IMI2_C1_S0_TEXT_DRAFT%2023%20May%202013.pdf>

Discoery and validation of novel endpoints in retinal diseases Indicative Text<http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_Call1/IMI2_C1_S0_TEXT_DRAFT%2023%20May%202013.pdf>

Future Topic – Date of launch TBC

RADAR: Remote assessment of disease and relapse Indicative Text<http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_Call1/IMI2_RADAR_Summary.pdf>

Under IMI2, the Medical Research Council will continue to run the networking costs scheme to help with the costs incurred in building a consortium and preparing an IMI2 proposal. More information is available here<http://www.mrc.ac.uk/research/international/innovative-medicines-initiative>.